← ANALYSTS · TIPRANKS
Robert LeBoyer · Noble Financial
Hits
27%
99 of 368 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
−14.2%
Over a year after the rating, TipRanks’ measure
Our companies rated now
7
Buy / hold / sell: 7 / 0 / 0
Upside of the analyst’s targets
+595.9%
Average over 7 current targets, to the last price
The market’s answer to the ratings
−1.4%
Day-0 move against SPY in the rating’s direction, average over 1 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Sep 28on TipRanks 09:10 | OCGNIWMOcugen · $276M | Reiterated | Buy | $12.00 | +1,438.5% | +1.7%next day +6.0% · 5 days −0.2% | ↗ |
| Sep 23on TipRanks 09:10 | ELDNIWMEledon Pharmaceuticals · $184M | Reiterated | Buy | $10.00 | +369.5% | −5.2%next day −1.4% · 5 days −6.3% | ↗ |
| Aug 13on TipRanks 09:10 | UNCYIWMUnicycive Therapeutics · $100M | Reiterated | Buy | $50.00 | +1,388.1% | −0.5%next day +2.2% · 5 days +2.9% | ↗ |
| Aug 10on TipRanks 09:10 | GYREIWMGyre Therapeutics · $679M | Reiterated | Buy | $20.00 | +228.9% | +0.8%next day −0.9% · 5 days +1.4% | ↗ |
| Jun 2on TipRanks 09:30 | GLSIIWMGreenwich LifeSciences · $226M | Reiterated | Buy | $45.00 | +209.3% | −14.9%next day +0.7% · 5 days −5.5% | ↗ |
| May 8on TipRanks Aug 7 08:50 | STLNIWMStarling Oncology Institute · $691M | Reiterated | Buy | $8.00 | +24.4% | −2.5%next day 0.0% · 5 days −0.7% | ↗ |
| Mar 16on TipRanks 09:10 | TNXPIWMTonix Pharma · $110M | Reiterated | Buy | $70.00 → $37.00−47.1% | +512.6% | +1.4%next day +10.1% · 5 days +20.4% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗